| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 12,245 | 12,351 | 11,823 | 10,775 | | Cost of Revenue | 7,027 | 7,639 | 7,240 | 6,317 | | | Gross Profit | 5,218 | 4,712 | 4,583 | 4,458 | | | Operating Expenses | | Research Development | 1,128 | 1,142 | 1,265 | 1,248 | | Selling General and Administrative | 2,694 | 3,173 | 3,176 | 3,114 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
| (141) | 71 | 70 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,396 | 538 | 71 | 26 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 90 | 65 | 73 | 91 | | Earnings Before Interest And Taxes | 1,486 | 603 | 144 | 117 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 1,486 | 603 | 144 | 117 | | Income Tax Expense | 52 | 7 | 6 |
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,434 | 596 | 138 | 117 | | | Non-recurring Events | | Discontinued Operations | (22) | (557) | 160 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,412 | 39 | 298 | 117 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,412 | $39 | $298 | $117 |
|
0.51% Nasdaq 
Income Statement
